This consortium is to use this additional funding over the next two years to accelerate the development of a treatment for anaemia initiated by GlycoForm.
Through combining the sugar synthesis and conjugation technology of GlycoForm, the unique PEGylation expertise of PolyTherics and Aston University’s yeast expression capability, the consortium will explore the development of next generation products for the treatment of anaemia. A product with an improved safety profile and an extended half-life is in increasing demand in this £5 billion market.
Michael Short, GlycoForm’s CEO, commented: “We are delighted that this peer reviewed funding will enable us to further accelerate our lead therapeutic product programme for the treatment of anaemia with such an outstanding consortium. This fits well with our existing collaborative programmes of drug modification with sugars to improve treatments for patients”.
Keith Powell, PolyTherics’ CEO, said: “This collaboration complements PolyTherics’ strategy of leveraging our proprietary technologies into best in class bio-therapeutics. Through our existing partnerships, we are already exploring the benefits that come from targeted, controlled modulation of protein half-life. We anticipate being able to apply our capabilities with equal impact to the goals of this new consortium”.
Margaret Henry | alfa
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf
The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.
Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...
Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.
Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
20.02.2020 | Physics and Astronomy
20.02.2020 | Physics and Astronomy
20.02.2020 | Power and Electrical Engineering